Interplay between HIV Entry and Transportin-SR2 Dependency

Retrovirology

Volumn 8, Issue , 2011, Pages

  Thys, Wannes ^a   De Houwer, Stéphanie ^a   Demeulemeester, Jonas ^a   Taltynov, Oliver ^a   Vancraenenbroeck, Renée ^b   Gérard, Melanie ^b   De Rijck, Jan ^a   Gijsbers, Rik ^a   Christ, Frauke ^a   Debyser, Zeger ^a  

^a DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSPORTIN SR2; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS GLYCOPROTEIN; VIRUS PROTEIN; KARYOPHERIN BETA;

ARTICLE; CELL CULTURE; CONTROLLED STUDY; EBOLA VIRUS; ENDOCYTOSIS; GENETIC TRANSFECTION; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LENTIVIRINAE; MEASLES VIRUS; MURINE LEUKEMIA VIRUS; NONHUMAN; PHENOTYPE; VESICULAR STOMATITIS VIRUS; VIRUS CAPSID; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS MUTANT; VIRUS REPLICATION; WILD TYPE; CELL LINE; HUMAN; METABOLISM; PHYSIOLOGY;

EBOLA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MEASLES VIRUS; MIRIDAE; MURINE LEUKEMIA VIRUS; VESICULAR STOMATITIS VIRUS;

BETA KARYOPHERINS; CELL LINE; HIV-1; HUMANS; VIRUS INTERNALIZATION;

EID: 79251574151     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-8-7     Document Type: Article

References (76)

1. Lewis P, Hensel M, Emerman M. Human immunodeficiency virus infection of cells arrested in the cell cycle. EMBO J 1992, 11:3053-3058. 556788, 1322294.
2. Hatziioannou T, Goff SP. Infection of nondividing cells by Rous sarcoma virus. Journal of virology 2001, 75:9526-9531. 10.1128/JVI.75.19.9526-9531.2001, 114520, 11533215.
3. Lewis PF, Emerman M. Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. Journal of virology 1994, 68:510-516. 236313, 8254763.
4. Bukrinsky MI, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, Haggerty S, Stevenson M. Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci USA 1992, 89:6580-6584. 10.1073/pnas.89.14.6580, 49545, 1631159.
5. Roe T, Reynolds TC, Yu G, Brown PO. Integration of murine leukemia virus DNA depends on mitosis. EMBO J 1993, 12:2099-2108. 413431, 8491198.
6. Yamashita M, Emerman M. Capsid is a dominant determinant of retrovirus infectivity in nondividing cells. Journal of virology 2004, 78:5670-5678. 10.1128/JVI.78.11.5670-5678.2004, 415837, 15140964.
7. Yamashita M, Perez O, Hope TJ, Emerman M. Evidence for direct involvement of the capsid protein in HIV infection of nondividing cells. PLoS Pathog 2007, 3:1502-1510. 10.1371/journal.ppat.0030156, 2042020, 17967060.
8. Arhel N. Revisiting HIV-1 uncoating. Retrovirology 2010, 7:96. 10.1186/1742-4690-7-96, 2998454, 21083892.
9. Beck M, Forster F, Ecke M, Plitzko JM, Melchior F, Gerisch G, Baumeister W, Medalia O. Nuclear pore complex structure and dynamics revealed by cryoelectron tomography. Science 2004, 306:1387-1390. 10.1126/science.1104808, 15514115.
10. Miller MD, Farnet CM, Bushman FD. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. Journal of virology 1997, 71:5382-5390. 191777, 9188609.
11. De Rijck J, Vandekerckhove L, Christ F, Debyser Z. Lentiviral nuclear import: a complex interplay between virus and host. Bioessays 2007, 29:441-451. 10.1002/bies.20561, 17450594.
12. Gallay P, Stitt V, Mundy C, Oettinger M, Trono D. Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import. Journal of virology 1996, 70:1027-1032. 189908, 8551560.
13. Gallay P, Hope T, Chin D, Trono D. HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway. Proc Natl Acad Sci USA 1997, 94:9825-9830. 10.1073/pnas.94.18.9825, 23276, 9275210.
14. Hearps AC, Jans DA. HIV-1 integrase is capable of targeting DNA to the nucleus via an importin alpha/beta-dependent mechanism. Biochem J 2006, 398:475-484. 10.1042/BJ20060466, 1559465, 16716146.
15. Nitahara-Kasahara Y, Kamata M, Yamamoto T, Zhang X, Miyamoto Y, Muneta K, Iijima S, Yoneda Y, Tsunetsugu-Yokota Y, Aida Y. Novel nuclear import of Vpr promoted by importin alpha is crucial for human immunodeficiency virus type 1 replication in macrophages. Journal of virology 2007, 81:5284-5293. 10.1128/JVI.01928-06, 1900242, 17344301.
16. Fassati A, Gorlich D, Harrison I, Zaytseva L, Mingot JM. Nuclear import of HIV-1 intracellular reverse transcription complexes is mediated by importin 7. EMBO J 2003, 22:3675-3685. 10.1093/emboj/cdg357, 165627, 12853482.
17. Zielske SP, Stevenson M. Importin 7 may be dispensable for human immunodeficiency virus type 1 and simian immunodeficiency virus infection of primary macrophages. Journal of virology 2005, 79:11541-11546. 10.1128/JVI.79.17.11541-11546.2005, 1193637, 16103209.
18. Ao Z, Huang G, Yao H, Xu Z, Labine M, Cochrane AW, Yao X. Interaction of human immunodeficiency virus type 1 integrase with cellular nuclear import receptor importin 7 and its impact on viral replication. J Biol Chem 2007, 282:13456-13467. 10.1074/jbc.M610546200, 17360709.
19. Zaitseva L, Cherepanov P, Leyens L, Wilson SJ, Rasaiyaah J, Fassati A. HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome. Retrovirology 2009, 6:11. 10.1186/1742-4690-6-11, 2660290, 19193229.
20. Ao Z, Danappa Jayappa K, Wang B, Zheng Y, Kung S, Rassart E, Depping R, Kohler M, Cohen EA, Yao X. Importin alpha3 interacts with HIV-1 integrase and contributes to HIV-1 nuclear import and replication. Journal of virology 2010, 84:8650-8663. 10.1128/JVI.00508-10, 20554775.
21. Christ F, Thys W, De Rijck J, Gijsbers R, Albanese A, Arosio D, Emiliani S, Rain JC, Benarous R, Cereseto A, Debyser Z. Transportin-SR2 imports HIV into the nucleus. Curr Biol 2008, 18:1192-1202. 10.1016/j.cub.2008.07.079, 18722123.
22. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319:921-926. 10.1126/science.1152725, 18187620.
23. Konig R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, Kuhen KL, Bandyopadhyay S, Ideker T, Orth AP, Miraglia LJ, Bushman FD, Young JA, Chanda SK. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135:49-60. 10.1016/j.cell.2008.07.032, 2628946, 18854154.
24. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, Espeseth AS. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 2008, 4:495-504. 10.1016/j.chom.2008.10.004, 18976975.
25. Yeung ML, Houzet L, Yedavalli VS, Jeang KT. A genome-wide short hairpin RNA screening of jurkat T-cells for human proteins contributing to productive HIV-1 replication. J Biol Chem 2009, 284:19463-19473. 10.1074/jbc.M109.010033, 2740572, 19460752.
26. Kataoka N, Bachorik JL, Dreyfuss G. Transportin-SR, a nuclear import receptor for SR proteins. J Cell Biol 1999, 145:1145-1152. 10.1083/jcb.145.6.1145, 2133142, 10366588.
27. Lai MC, Lin RI, Huang SY, Tsai CW, Tarn WY. A human importin-beta family protein, transportin-SR2, interacts with the phosphorylated RS domain of SR proteins. J Biol Chem 2000, 275:7950-7957. 10.1074/jbc.275.11.7950, 10713112.
28. Lai MC, Lin RI, Tarn WY. Transportin-SR2 mediates nuclear import of phosphorylated SR proteins. Proc Natl Acad Sci USA 2001, 98:10154-10159. 10.1073/pnas.181354098, 56931, 11517331.
29. Lai MC, Kuo HW, Chang WC, Tarn WY. A novel splicing regulator shares a nuclear import pathway with SR proteins. EMBO J 2003, 22:1359-1369. 10.1093/emboj/cdg126, 151058, 12628928.
30. Krishnan L, Matreyek KA, Oztop I, Lee K, Tipper CH, Li X, Dar MJ, Kewalramani VN, Engelman A. The requirement for cellular transportin 3 (TNPO3 or TRN-SR2) during infection maps to human immunodeficiency virus type 1 capsid and not integrase. Journal of virology 2010, 84:397-406. 10.1128/JVI.01899-09, 2798409, 19846519.
31. Yamashita M, Emerman M. The cell cycle independence of HIV infections is not determined by known karyophilic viral elements. PLoS Pathog 2005, 1:e18. 10.1371/journal.ppat.0010018, 1283251, 16292356.
32. Lee K, Ambrose Z, Martin TD, Oztop I, Mulky A, Julias JG, Vandegraaff N, Baumann JG, Wang R, Yuen W, Takemura T, Shelton K, Taniuchi I, Li Y, Sodroski J, Littman DR, Coffin JM, Hughes SH, Unutmaz D, Engelman A, KewalRamani VN. Flexible use of nuclear import pathways by HIV-1. Cell Host Microbe 2010, 7:221-233. 10.1016/j.chom.2010.02.007, 20227665.
33. Charneau P, Clavel F. A single-stranded gap in human immunodeficiency virus unintegrated linear DNA defined by a central copy of the polypurine tract. Journal of virology 1991, 65:2415-2421. 240594, 2016765.
34. Charneau P, Mirambeau G, Roux P, Paulous S, Buc H, Clavel F. HIV-1 reverse transcription. A termination step at the center of the genome. J Mol Biol 1994, 241:651-662. 10.1006/jmbi.1994.1542, 7520946.
35. Zennou V, Petit C, Guetard D, Nerhbass U, Montagnier L, Charneau P. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 2000, 101:173-185. 10.1016/S0092-8674(00)80828-4, 10786833.
36. Van Maele B, De Rijck J, De Clercq E, Debyser Z. Impact of the central polypurine tract on the kinetics of human immunodeficiency virus type 1 vector transduction. Journal of virology 2003, 77:4685-4694. 10.1128/JVI.77.8.4685-4694.2003, 152151, 12663775.
37. De Rijck J, Van Maele B, Debyser Z. Positional effects of the central DNA flap in HIV-1-derived lentiviral vectors. Biochem Biophys Res Commun 2005, 328:987-994. 10.1016/j.bbrc.2005.01.052, 15707975.
38. De Rijck J, Debyser Z. The central DNA flap of the human immunodeficiency virus type 1 is important for viral replication. Biochem Biophys Res Commun 2006, 349:1100-1110. 10.1016/j.bbrc.2006.08.141, 16962998.
39. Arhel NJ, Souquere-Besse S, Charneau P. Wild-type and central DNA flap defective HIV-1 lentiviral vector genomes: intracellular visualization at ultrastructural resolution levels. Retrovirology 2006, 3:38. 10.1186/1742-4690-3-38, 1538615, 16800894.
40. Arhel N, Munier S, Souque P, Mollier K, Charneau P. Nuclear import defect of human immunodeficiency virus type 1 DNA flap mutants is not dependent on the viral strain or target cell type. J Virol 2006, 80:10262-10269. 10.1128/JVI.00974-06, 1617309, 17005705.
41. Willard FS, Kimple AJ, Johnston CA, Siderovski DP. A direct fluorescence-based assay for RGS domain GTPase accelerating activity. Anal Biochem 2005, 340:341-351. 10.1016/j.ab.2005.02.015, 15840508.
42. Gotthardt K, Weyand M, Kortholt A, Van Haastert PJ, Wittinghofer A. Structure of the Roc-COR domain tandem of C. tepidum, a prokaryotic homologue of the human LRRK2 Parkinson kinase. EMBO J 2008, 27:2239-2249. 10.1038/emboj.2008.150, 2519104, 18650931.
43. Conner SD, Schmid SL. Regulated portals of entry into the cell. Nature 2003, 422:37-44. 10.1038/nature01451, 12621426.
44. Smith EC, Popa A, Chang A, Masante C, Dutch RE. Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J 2009, 276:7217-7227. 10.1111/j.1742-4658.2009.07401.x, 2795005, 19878307.
45. Marechal V, Clavel F, Heard JM, Schwartz O. Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1. Journal of virology 1998, 72:2208-2212. 109517, 9499078.
46. Schwartz O, Marechal V, Friguet B, Arenzana-Seisdedos F, Heard JM. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1. Journal of virology 1998, 72:3845-3850. 109608, 9557668.
47. Schaeffer E, Soros VB, Greene WC. Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes. Journal of virology 2004, 78:1375-1383. 10.1128/JVI.78.3.1375-1383.2004, 321368, 14722292.
48. Miyauchi K, Kim Y, Latinovic O, Morozov V, Melikyan GB. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009, 137:433-444. 10.1016/j.cell.2009.02.046, 2696170, 19410541.
49. Beer C, Andersen DS, Rojek A, Pedersen L. Caveola-dependent endocytic entry of amphotropic murine leukemia virus. Journal of virology 2005, 79:10776-10787. 10.1128/JVI.79.16.10776-10787.2005, 1182675, 16051869.
50. Bhattacharyya S, Warfield KL, Ruthel G, Bavari S, Aman MJ, Hope TJ. Ebola virus uses clathrin-mediated endocytosis as an entry pathway. Virology 2010, 401:18-28. 10.1016/j.virol.2010.02.015, 20202662.
51. Aiken C. Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A. Journal of virology 1997, 71:5871-5877. 191842, 9223476.
52. Sun X, Yau VK, Briggs BJ, Whittaker GR. Role of clathrin-mediated endocytosis during vesicular stomatitis virus entry into host cells. Virology 2005, 338:53-60. 10.1016/j.virol.2005.05.006, 15936793.
53. Brindley MA, Maury W. Equine infectious anemia virus entry occurs through clathrin-mediated endocytosis. Journal of virology 2008, 82:1628-1637. 10.1128/JVI.01754-07, 2258727, 18057237.
54. Elder JH, Sundstrom M, de Rozieres S, de Parseval A, Grant CK, Lin YC. Molecular mechanisms of FIV infection. Vet Immunol Immunopathol 2008, 123:3-13. 10.1016/j.vetimm.2008.01.007, 2409060, 18289701.
55. Katen LJ, Januszeski MM, Anderson WF, Hasenkrug KJ, Evans LH. Infectious entry by amphotropic as well as ecotropic murine leukemia viruses occurs through an endocytic pathway. Journal of virology 2001, 75:5018-5026. 10.1128/JVI.75.11.5018-5026.2001, 114905, 11333881.
56. Nisole S, Saib A. Early steps of retrovirus replicative cycle. Retrovirology 2004, 1:9. 10.1186/1742-4690-1-9, 421752, 15169567.
57. Fassati A, Goff SP. Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus. Journal of virology 1999, 73:8919-8925. 112922, 10515996.
58. Fassati A, Goff SP. Characterization of intracellular reverse transcription complexes of human immunodeficiency virus type 1. Journal of virology 2001, 75:3626-3635. 10.1128/JVI.75.8.3626-3635.2001, 114854, 11264352.
59. Towers GJ. The control of viral infection by tripartite motif proteins and cyclophilin A. Retrovirology 2007, 4:40. 10.1186/1742-4690-4-40, 1906832, 17565686.
60. Naghavi MH, Goff SP. Retroviral proteins that interact with the host cell cytoskeleton. Curr Opin Immunol 2007, 19:402-407. 10.1016/j.coi.2007.07.003, 2040053, 17707624.
61. Anderson JL, Hope TJ. Intracellular trafficking of retroviral vectors: obstacles and advances. Gene Ther 2005, 12:1667-1678. 10.1038/sj.gt.3302591, 16292352.
62. Thys W, Busschots K, McNeely M, Voet A, Christ F, Debyser Z. LEDGF/p75 and transportin-SR2 are cellular cofactors of HIV integrase and novel targets for antiviral therapy. HIV Ther 2009, 3:171-188.
63. Geraerts M, Michiels M, Baekelandt V, Debyser Z, Gijsbers R. Upscaling of lentiviral vector production by tangential flow filtration. J Gene Med 2005, 7:1299-1310. 10.1002/jgm.778, 15906396.
64. Ibrahimi A, Vande Velde G, Reumers V, Toelen J, Thiry I, Vandeputte C, Vets S, Deroose C, Bormans G, Baekelandt V, Debyser Z, Gijsbers R. Highly efficient multicistronic lentiviral vectors with peptide 2A sequences. Hum Gene Ther 2009, 20:845-860. 10.1089/hum.2008.188, 19419274.
65. Naldini L, Blomer U, Gage FH, Trono D, Verma IM. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc Natl Acad Sci USA 1996, 93:11382-11388. 10.1073/pnas.93.21.11382, 38066, 8876144.
66. Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol 1997, 15:871-875. 10.1038/nbt0997-871, 9306402.
67. Mangeot PE, Duperrier K, Negre D, Boson B, Rigal D, Cosset FL, Darlix JL. High levels of transduction of human dendritic cells with optimized SIV vectors. Mol Ther 2002, 5:283-290. 10.1006/mthe.2002.0541, 11863418.
68. Nègre D, Mangeot PE, Duisit G, Blanchard S, Vidalain PO, Leissner P, Winter AJ, Rabourdin-Combe C, Mehtali M, Moullier P, Darlix JL, Cosset FL. Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther 2000, 7:1613-1623. 10.1038/sj.gt.3301292, 11083469.
69. Lin YL, Noel D, Mettling C, Reant B, Clot J, Jorgensen C, Corbeau P. Feline immunodeficiency virus vectors for efficient transduction of primary human synoviocytes: application to an original model of rheumatoid arthritis. Hum Gene Ther 2004, 15:588-596. 10.1089/104303404323142033, 15212717.
70. Olsen JC. Gene transfer vectors derived from equine infectious anemia virus. Gene Ther 1998, 5:1481-1487. 10.1038/sj.gt.3300768, 9930301.
71. Freed EO, Myers DJ, Risser R. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160. Journal of virology 1989, 63:4670-4675. 251101, 2677400.
72. Sena-Esteves M, Tebbets JC, Steffens S, Crombleholme T, Flake AW. Optimized large-scale production of high titer lentivirus vector pseudotypes. J Virol Methods 2004, 122:131-139. 10.1016/j.jviromet.2004.08.017, 15542136.
73. Medina MF, Kobinger GP, Rux J, Gasmi M, Looney DJ, Bates P, Wilson JM. Lentiviral vectors pseudotyped with minimal filovirus envelopes increased gene transfer in murine lung. Mol Ther 2003, 8:777-789. 10.1016/j.ymthe.2003.07.003, 14599811.
74. Funke S, Maisner A, Muhlebach MD, Koehl U, Grez M, Cattaneo R, Cichutek K, Buchholz CJ. Targeted cell entry of lentiviral vectors. Mol Ther 2008, 16:1427-1436. 10.1038/mt.2008.128, 18578012.
75. Maertens G, Cherepanov P, Pluymers W, Busschots K, De Clercq E, Debyser Z, Engelborghs Y. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 2003, 278:33528-33539. 10.1074/jbc.M303594200, 12796494.
76. Jonsson CB, Donzella GA, Roth MJ. Characterization of the forward and reverse integration reactions of the Moloney murine leukemia virus integrase protein purified from Escherichia coli. J Biol Chem 1993, 268:1462-1469.